PMID: 6981367Sep 1, 1982Paper

Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus

Annals of Internal Medicine
L D Sabath

Abstract

There are three major mechanisms of resistance of Staphylococcus aureus to beta-lactam antibiotics: enzyme mediated (penicillinase or beta-lactamase) by which the antibiotic is inactivated; intrinsic, which is not due to drug inactivation, and accounts for methicillin-resistance; and tolerance, in which there is a dissociation of the inhibitory and killing actions of beta-lactam antibiotics. In enzyme-mediated resistance, there are at least three different staphylococcal beta-lactamases, which probably account for differences in the inoculum effect with different cephalosporins. The intrinsic resistance is associated with differences in the affinity of beta-lactams for penicillin-binding proteins, but intrinsic resistance is probably more complex, because the pH of the medium, chelating agents, visible light, and temperature also effect its expression. Tolerance is clearly due to decreased autolytic enzyme activity (reflecting persistence of an enzyme inhibitor) of those tolerant organisms that need 32 (or more) times as much antibiotic for a bactericidal effect as for simple inhibition.

Citations

Aug 1, 1992·Journal of Clinical Pharmacology·E Rubinstein, R Lang
Jan 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H Liu, N Lewis
Dec 1, 1986·European Journal of Clinical Microbiology·J H Jorgensen
Oct 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H LiuD Jungkind
Feb 1, 1986·Diagnostic Microbiology and Infectious Disease·J L Ho, M S Klempner
Jun 4, 1999·Diagnostic Microbiology and Infectious Disease·F BekkaouiR N Bryan
May 31, 1984·The New England Journal of Medicine·J N Sheagren
Jun 5, 1998·The Pediatric Infectious Disease Journal·M H MacrisJ B Zabriskie
Dec 1, 1984·Antimicrobial Agents and Chemotherapy·L L Pelletier
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·R J FassL W Ayers
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·M J RybakL M Albrecht
Feb 1, 1988·Antimicrobial Agents and Chemotherapy·M Mateos-MoraJ A Washington
Nov 1, 1984·American Journal of Ophthalmology·J A KhanC H Ide
Jul 1, 1996·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·B JansenG Pulverer
Sep 16, 2008·Heart & Lung : the Journal of Critical Care·Burke A CunhaLawrence Eisenstein
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·UNKNOWN EORTC International Antimicrobial Therapy Cooperative Group
Sep 1, 1991·The Journal of Hospital Infection·M H Grosserode, R P Wenzel
Aug 18, 2004·Diagnostic Microbiology and Infectious Disease·Zmira SamraJudi Bahar
Apr 1, 1993·The Journal of Hospital Infection·Y KobayashiY Ikeda
Apr 28, 2005·The Lancet Infectious Diseases·Nicola ZetolaWilliam R Bishai
Jun 6, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Abbas YadegarGholam Reza Goudarzi
Dec 20, 2005·Expert Review of Molecular Diagnostics·Robert D JenisonDavid C Ward
Jan 1, 1991·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J H Jorgensen
Feb 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dorota Jakubczyk, Francois Dussart
May 11, 2021·ACS Nano·Mohamed A Abdou MohamedWarren C W Chan
Oct 1, 1991·Journal of Clinical Microbiology·K MurakamiS Watanabe
Jun 1, 1991·Journal of Clinical Microbiology·Y TvetenT Hofstad
Aug 1, 1986·Journal of Clinical Microbiology·J G La Zonby, M J Starzyk
May 1, 1987·Journal of Clinical Microbiology·M E MulliganL Johnston
Mar 1, 1987·Microbiological Reviews·B R Lyon, R Skurray
Apr 1, 2003·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·P T WakodeR Bajoriya

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.